ProCE Banner Activity

Islatravir Updates From CROI 2023: Perspectives From Western Europe

Conference Coverage
Clinical Thought

Read my take on key islatravir updates reported at CROI 2023, including an overview of safety findings on total lymphocyte and CD4+ counts from HIV treatment and prevention studies and efficacy results from phase III switch studies involving virologically suppressed people with HIV receiving stable ART.

Released: March 17, 2023

Expiration: March 15, 2024



Laura Waters

Laura Waters, FRCP, MD

Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
London, United Kingdom


Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Laura Waters, MD: consultant: Cipla, Gilead Sciences, Janssen, Merck, Mylan, ViiV Healthcare.